Isoprenaline Hydrochloride Synchrony Pharma

Isoprenaline Hydrochloride, the active ingredient in Isoprenaline Hydrochloride Synchrony Pharma, is a beta‑adrenergic agonist presented as an injectable solution for intravenous use. It is employed to increase heart rate and improve bronchodilation in patients with bradycardia, heart block, asthma or bronchospasm. GNH USA supplies Isoprenaline Hydrochloride Synchrony Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Isoprenaline Hydrochloride acts on the beta‑adrenergic system to treat several cardiac and respiratory conditions. - Bradycardia: raises heart rate to maintain adequate cardiac output. - Heart block: improves conduction through the atrioventricular node. - Asthma: relaxes bronchial smooth muscle to relieve airway obstruction. - Bronchospasm: provides rapid bronchodilation during acute episodes.

Isoprenaline Hydrochloride may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Tachycardia: rapid increase in heart rate. - Palpitations: awareness of heart beating. - Headache: mild to moderate intensity. - Tremor: fine muscle shaking. - Nausea: occasional stomach upset. - Hypertension: elevated blood pressure.

Serious or Rare Side Effects: - Life‑threatening arrhythmias. - Myocardial ischemia or infarction. - Severe hypotension. - Pulmonary edema. - Anaphylactic or severe allergic reactions. - Extreme bronchospasm despite therapy.

Careful clinical monitoring is required when using Isoprenaline Hydrochloride. - Cardiac monitoring: observe heart rate and rhythm continuously. - Coronary artery disease: use with caution due to increased myocardial oxygen demand. - Uncontrolled hypertension: avoid or adjust dose. - Renal impairment: consider dose reduction. - Pheochromocytoma: contraindicated because of catecholamine surge. - Store at room temperature: keep in original container, protect from moisture and light.

Isoprenaline Hydrochloride can interact with several drug classes, altering its efficacy or safety.

Major Interactions (Avoid): - Non‑selective beta‑blockers: may blunt therapeutic effect. - MAO inhibitors: increase risk of hypertensive crisis. - Tricyclic antidepressants: potentiate cardiovascular stimulation. - Other sympathomimetics: may cause excessive tachycardia. - Ergot alkaloids: increase risk of severe vasospasm.

Moderate Interactions (Monitor Closely): - Calcium channel blockers: may enhance negative inotropic effects. - Digoxin: risk of arrhythmias. - Diuretics: electrolyte shifts can affect cardiac response. - Anesthetic agents: may alter hemodynamic stability. - Antihypertensives: may require dose adjustments.